Virtus ETF Advisers’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$196K Buy
38,324
+7,683
+25% +$41.9K 0.07% 295
2026
Q2
$161K Buy
30,641
+1,473
+5% +$7.75K 0.06% 311
2026
Q1
$122K Hold
29,168
– – 0.06% 311
2025
Q4
$140K Hold
29,168
– – 0.07% 295
2025
Q3
$148K Buy
+29,168
New +$129K 0.08% 252

Other funds holding SRTA

Virtus ETF Advisers's SRTA Position: Q3 2026 in Review

Virtus ETF Advisers increased its Strata Critical Medical Inc (SRTA) stake by 25% in Q3 2026, buying an estimated $41.9K and bringing the position to 38,324 shares worth $196K. The position accounts for 0.07% of the portfolio, ranked #295.

Virtus ETF Advisers first reported a position in SRTA in Q3 2025 and has held it in 5 quarters since. 91 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

  • Virtus ETF Advisers held 38,324 shares of Strata Critical Medical Inc worth $196K as of Q3 2026.
  • Virtus ETF Advisers bought 7,683 Strata Critical Medical Inc shares in Q3 2026, an estimated $41.9K.
  • Strata Critical Medical Inc made up 0.07% of Virtus ETF Advisers's portfolio in Q3 2026, its #295 holding.
  • Virtus ETF Advisers first reported a position in Strata Critical Medical Inc in Q3 2025 and has held it in 5 quarters since.
  • 91 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2026.

Based on Virtus ETF Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.